SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-028551
Filing Date
2022-11-07
Accepted
2022-11-07 08:48:15
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrsn-20220930.htm   iXBRL 10-Q 1628254
2 EX-10.1 exhibit101.htm EX-10.1 1260299
3 EX-31.1 exhibit31110-qfy2022q3.htm EX-31.1 11206
4 EX-31.2 exhibit31210-qfy2022q3.htm EX-31.2 11170
5 EX-32.1 exhibit32110-qfy2022q3.htm EX-32.1 5806
  Complete submission text file 0001628280-22-028551.txt   7759430

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrsn-20220930.xsd EX-101.SCH 39610
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrsn-20220930_cal.xml EX-101.CAL 46477
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrsn-20220930_def.xml EX-101.DEF 198041
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrsn-20220930_lab.xml EX-101.LAB 494716
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrsn-20220930_pre.xml EX-101.PRE 339020
62 EXTRACTED XBRL INSTANCE DOCUMENT mrsn-20220930_htm.xml XML 942288
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 221363890
SIC: 2834 Pharmaceutical Preparations